聚乙二醇化羧基血红蛋白携氧载体与羟乙基淀粉在大鼠短暂失血性休克模型中的复苏效果:微循环与全身影响
研究采用雄性Sprague Dawley大鼠(N=20)建立重度控制性失血性休克模型,随机接受20%估计血容量的6%羟乙基淀粉或PEG-COHb复苏,持续有创监测心血管指标与动脉血气,并用活体显微镜与磷光淬灭显微镜测量骨骼肌间质氧分压(PISFO2)与血管活性。失血使两组平均动脉压、小动脉直径与PISFO2下降、乳酸升高约10倍;两种液体均改善心血管参数,但PEG-COHb组平均动脉压更高(P<0.001)、PISFO2更高(14 vs 5 mmHg,P<0.0001)、复苏后乳酸更低(P<0.01)、存活时间由90分钟延长至142分钟(P<0.001)。作者认为PEG-COHb复苏未出现高血压与血管活性反应,支持进一步研究该复苏策略。
要点
- 大鼠重度控制性失血性休克模型中,20%估计血容量复苏用PEG-COHb较6%羟乙基淀粉平均动脉压更高(P<0.001)。
- PEG-COHb组骨骼肌间质氧分压为14 mmHg,羟乙基淀粉组为5 mmHg(P<0.0001),PEG-COHb组更高。
- 复苏后乳酸PEG-COHb组低于羟乙基淀粉组(P<0.01)。
- 存活时间PEG-COHb组142分钟 vs 羟乙基淀粉组90分钟(P<0.001),PEG-COHb组延长。
- 作者报告PEG-COHb复苏未检测到高血压与血管活性反应,支持进一步研究该复苏策略。
适用人群与场景
- 雄性Sprague Dawley大鼠(N=20),重度、控制性失血性休克模型
- 动物在失血性休克后随机接受20%估计血容量的6%羟乙基淀粉或PEG-COHb复苏
处置流程与药物剂量
- 失血性休克动物随机接受20%估计血容量的6%羟乙基淀粉或PEG-COHb进行复苏
- 持续有创心血管监测与动脉血气分析,并以活体显微镜与磷光淬灭显微镜测量骨骼肌间质氧分压(PISFO2)与血管活性
研究设计与关键结果
- 研究类型:大鼠重度控制性失血性休克模型的随机对照动物实验,样本量N=20
- 干预与对照:20%估计血容量复苏,PEG-COHb vs 6%羟乙基淀粉
- 失血使两组平均动脉压、小动脉直径与PISFO2下降,乳酸升高10倍
- 两种液体均改善心血管参数;PEG-COHb组平均动脉压更高(P<0.001)
- PISFO2:PEG-COHb组14 mmHg vs 羟乙基淀粉组5 mmHg(P<0.0001)
- 复苏后乳酸:PEG-COHb组低于羟乙基淀粉组(P<0.01)
- 存活时间:PEG-COHb组142分钟 vs 羟乙基淀粉组90分钟(P<0.001)
- PEG-COHb复苏未检测到高血压与血管活性反应
证据类型、等级与局限
- 证据类型:动物实验(大鼠失血性休克模型)
- 局限:原文未报告局限性
对床旁实践的改变
- 作者认为PEG-COHb复苏未出现高血压与血管活性反应,支持进一步研究该复苏策略
- 结果为重度控制性失血性休克大鼠模型中的动物实验数据,非临床推荐
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Hemorrhage is the leading cause of preventable, traumatic death. Currently, prehospital resuscitation fluids provide preload but not oxygen-carrying capacity-a critical blood function that mitigates microvascular ischemia and tissue hypoxia during hemorrhagic shock. Solutions containing polymerized hemoglobin have been associated with vasoactive and hypertensive events. A novel hemoglobin-based oxygen carrier, modified with PEGylation and CO moieties (PEG-COHb), may overcome these limitations.
OBJECTIVES: To evaluate the systemic and microcirculatory effects of PEG-COHb as compared with the 6% hetastarch in a rat model of hemorrhagic shock.
METHODS: Male Sprague Dawley rats (N = 20) were subjected to severe, controlled, hemorrhagic shock. Animals were randomized to 20% estimated blood-volume resuscitation with either 6% hetastarch or PEG-COHb. Continuous, invasive, cardiovascular measurements, and arterial blood gases were measured. Microcirculatory measurements of interstitial oxygenation (PISFO2) and vasoactivity helped model oxygen delivery in the spinotrapezius muscle using intravital and phosphorescence quenching microscopy.
RESULTS: Hemorrhage reduced mean arterial pressure (MAP), arteriolar diameter, and PISFO2, and increased lactate 10-fold in both groups. Resuscitation with both PEG-COHb and hetastarch improved cardiovascular parameters. However, PEG-COHb treatment resulted in higher MAP (P < 0.001), improved PISFO2 (14 [PEG-COHb] vs. 5 [hetastarch] mmHg; P < 0.0001), lower lactate post-resuscitation (P < 0.01), and extended survival from 90 to 142 min (P < 0.001) as compared with the hetastarch group.
CONCLUSIONS: PEG-COHb improved MAP PISFO2, lactate, and survival time as compared with 6% hetastarch resuscitation. Importantly, hypertension and vasoactivity were not detected in response to PEG-COHb resuscitation supporting further investigation of this resuscitation strategy.
参考来源
- Nugent WH, Sheppard FR, Dubick MA, et al. Microvascular and Systemic Impact of Resuscitation with PEGylated Carboxyhemoglobin-Based Oxygen Carrier or Hetastarch in a Rat Model of Transient Hemorrhagic Shock. Shock. 2020. PMID: 31045989. doi:10.1097/SHK.0000000000001370
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。